Pacira Pharmaceuticals Inc (PCRX) Insider Trading
- $1,702,348.30
- $212,310,287.06
- Jan. 6, 2025
- Andreas Wicki
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 7, 2020 | VP | 170 | $46.81 | Sell | $7,957.70 | |
Jan. 15, 2020 | CEO | 25,000 | $42.68 | Sell | $1,067,000.00 | |
Dec. 16, 2019 | Insider | 3,671 | $45.79 | Sell | $168,095.09 | |
Dec. 2, 2019 | Director | 1,300 | $46.13 | Sell | $59,969.00 | |
Nov. 20, 2019 | VP | 1,176 | $44.14 | Sell | $51,908.64 | |
Nov. 15, 2019 | CEO | 70,000 | $44.47 | Sell | $3,112,900.00 | |
Nov. 11, 2019 | VP | 5,000 | $43.59 | Sell | $217,950.00 | |
Aug. 15, 2019 | CEO | 12,849 | $39.15 | Sell | $503,038.35 | |
Aug. 14, 2019 | Insider | 6,252 | $39.49 | Sell | $246,891.48 | |
July 8, 2019 | CEO | 13,115 | $42.88 | Sell | $562,371.20 | |
June 10, 2019 | VP | 2,126 | $44.28 | Sell | $94,139.28 | |
June 5, 2019 | Insider | 9,040 | $43.10 | Sell | $389,624.00 | |
June 4, 2019 | CFO | 1,106 | $42.91 | Sell | $47,458.46 | |
June 4, 2019 | SVP | 430 | $42.91 | Sell | $18,451.30 | |
June 4, 2019 | CEO | 12,385 | $42.91 | Sell | $531,440.35 | |
June 4, 2019 | CAO | 2,529 | $42.91 | Sell | $108,519.39 | |
June 4, 2019 | VP | 967 | $42.91 | Sell | $41,493.97 | |
June 4, 2019 | Director | 782 | $42.66 | Sell | $33,360.12 | |
June 3, 2019 | Insider | 15,510 | $43.21 | Sell | $670,187.10 | |
March 6, 2019 | Director | 1,700 | $38.97 | Buy | $66,249.00 | |
Dec. 13, 2018 | Director | 14,527 | $46.84 | Sell | $680,444.68 | |
Nov. 19, 2018 | Director | 4,500 | $46.18 | Buy | $207,810.00 | |
Nov. 16, 2018 | Director | 70,498 | $47.34 | Sell | $3,337,375.32 | |
Nov. 15, 2018 | CEO | 15,000 | $47.39 | Sell | $710,850.00 | |
Nov. 12, 2018 | Director | 5,478 | $49.83 | Sell | $272,968.74 | |
Nov. 9, 2018 | Director | 58,245 | $51.11 | Sell | $2,976,901.95 | |
Nov. 7, 2018 | Director | 4,000 | $51.29 | Buy | $205,160.00 | |
Nov. 2, 2018 | VP | 1,000 | $54.35 | Sell | $54,350.00 | |
Sept. 24, 2018 | VP | 1,000 | $50.70 | Sell | $50,700.00 | |
Aug. 28, 2018 | Director | 1,000 | $44.61 | Buy | $44,610.00 | |
Aug. 22, 2018 | VP | 1,667 | $44.48 | Sell | $74,148.16 | |
Aug. 15, 2018 | CEO | 33,062 | $47.32 | Sell | $1,564,493.84 | |
Aug. 14, 2018 | CAO | 4,773 | $47.04 | Sell | $224,521.92 | |
June 7, 2018 | CEO | 18,406 | $36.28 | Sell | $667,769.68 | |
June 4, 2018 | CAO | 2,040 | $33.02 | Sell | $67,360.80 | |
June 4, 2018 | Director | 771 | $33.90 | Sell | $26,136.90 | |
June 4, 2018 | Insider | 1,367 | $33.02 | Sell | $45,138.34 | |
June 4, 2018 | CFO | 708 | $33.02 | Sell | $23,378.16 | |
June 4, 2018 | VP | 801 | $33.02 | Sell | $26,449.02 | |
May 15, 2018 | CEO | 25,000 | $33.79 | Sell | $844,750.00 | |
Jan. 10, 2018 | CEO | 28,885 | $40.19 | Sell | $1,160,888.15 | |
Dec. 15, 2017 | VP | 340 | $43.70 | Sell | $14,858.00 | |
Nov. 20, 2017 | SVP | 850 | $41.11 | Sell | $34,943.50 | |
Nov. 17, 2017 | CAO | 10,000 | $40.00 | Sell | $400,000.00 | |
Nov. 15, 2017 | CEO | 58,885 | $38.34 | Sell | $2,257,650.90 | |
Nov. 10, 2017 | Director | 1,000 | $41.60 | Buy | $41,600.00 | |
Aug. 22, 2017 | Director | 1,044 | $36.15 | Sell | $37,740.60 | |
Aug. 15, 2017 | CAO | 3,461 | $36.75 | Sell | $127,191.75 | |
Aug. 15, 2017 | CEO | 28,885 | $36.37 | Sell | $1,050,547.45 | |
Aug. 8, 2017 | Director | 100 | $37.13 | Buy | $3,713.00 |
Insiders are both buying and selling Pacira Pharmaceuticals Inc stock.
The insider traders at Pacira Pharmaceuticals Inc are: Andreas Wicki, Lauren Bullaro Riker, David M Stack, Kristen Marie Williams, David M. Stack, Paul J Hastings, James S Scibetta, Roy Winston, Max Reinhardt, Daryl Gaugler, Gary W Pace, John P Phd Longenecker, Charles A Reinhart III, Gary Patou, Charles Anthony Laranjeira, Jonathan Slonin, Mark A Kronenfeld, Taunia Markvicka, Luke Evnin, Mark Froimson, Richard Scranton, John Phd Longenecker, James B Jones, John Pratt, Fred A Middleton, Laura Brege, David Stack, Scott Braunstein, Anthony Molloy, James Scibetta, James B. Jones, Marcelo Bigal, Donald C Manning, James S. Scibetta, HASTINGS PAUL J, Dennis Mcloughlin, Kristen Williams, Dennis L Winger, Frank D Lee, and Lauren Riker
The most active insider trader at Pacira Pharmaceuticals Inc is Andreas Wicki with 38 trades.
Andreas Wicki has sold the most Pacira Pharmaceuticals Inc stock with a total value of $103,301,745.13.
Gary W Pace has bought the most Pacira Pharmaceuticals Inc stock with a total value of $714,610.00.
The most recent insider trade for Pacira Pharmaceuticals Inc was on Jan. 6, 2025.
The single biggest insider buy for Pacira Pharmaceuticals Inc was from James S Scibetta with a total value of $306,850.00 on Sept. 11, 2015.
The single biggest insider sell for Pacira Pharmaceuticals Inc was from Andreas Wicki with a total value of $15,187,500.00 on Aug. 11, 2014.